Active Wound Care or Wound Care Market accounted to USD 817.6 million in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. - SocioHerald
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Comments
Post a Comment